News, Publications & Insights

Explore the latest news and publications, innovation milestones, and drug-device insights from PARI and our pharmaceutical partners leveraging eFlow® Technology.

PARI Partner Project News

Partner Project News

Enterprise Therapeutics achieves primary efficacy outcome in Phase 2 clinical trial for cystic fibrosis with novel inhaled ENaC blocker ETD001

PARI Publication

PARI Publication

A Novel Human Factors Approach for a New Platform-Based, Breath-Triggered Nebuliser

Published

Monday, 25. April 2022

Category

PARI Publications

Towards More Realistic In Vitro Nebulizer Testing.

Towards More Realistic In Vitro Nebulizer Testing.

Published

Monday, 25. April 2022

Category

PARI Publications

Unsteady Aerosol Output Rate Measurements: Assessing the eFlow Nebulizer Aerosol Bolus.

Unsteady Aerosol Output Rate Measurements: Assessing the eFlow Nebulizer Aerosol Bolus.

Published

Thursday, 21. April 2022

Category

PARI Publications

Development of a Novel Test Stand for the Measurement of Valved Holding Chambers with Facemasks.

Development of a Novel Test Stand for the Measurement of Valved Holding Chambers with Facemasks.

Published

Thursday, 13. January 2022

Category

Publications

A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation.

A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation.

Published

Wednesday, 12. January 2022

Category

Publications

Inhaled Medicines: Past, Present, and Future

Inhaled Medicines: Past, Present, and Future

Contact us

eFlow-partneringpari.com

Two smiling men in a blue circle. The central man wears glasses and a light blue shirt. The man on the left has a beard and a blue patterned shirt.

PARI Business Development Team